Global and United States Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2027

Publisher Name :
Date: 25-Oct-2021
No. of pages: 149
Inquire Before Buying

Interventional X-ray Contrast and Imaging Agents market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Interventional X-ray Contrast and Imaging Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Interventional X-ray Contrast and Imaging Agents market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Iodinated Contrast Media

- Barium-Based Contrast Media

- Microbubble Contrast Media

- Other

Segment by Application

- Heart Disease

- Neurological

- Urology

- General Surgery

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Bracco

- General Electric

- Guerbet

- Fujifilm Visualsonics

- Imax

- J.B. Chemicals & Pharmaceuticals

- Jodas Expoim

- Lantheus Medical Imaging

- Nano Therapeutics

- Novalek Pharmaceuticals

- Taejoon Pharm

- Unijules Life Sciences

Global and United States Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Interventional X-ray Contrast and Imaging Agents Product Introduction
1.2 Market by Type
1.2.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type
1.2.2 Iodinated Contrast Media
1.2.3 Barium-Based Contrast Media
1.2.4 Microbubble Contrast Media
1.2.5 Other
1.3 Market by Application
1.3.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application
1.3.2 Heart Disease
1.3.3 Neurological
1.3.4 Urology
1.3.5 General Surgery
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Interventional X-ray Contrast and Imaging Agents Market Size, Estimates and Forecasts
2.1.1 Global Interventional X-ray Contrast and Imaging Agents Revenue 2016-2027
2.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales 2016-2027
2.2 Global Interventional X-ray Contrast and Imaging Agents, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Interventional X-ray Contrast and Imaging Agents Historical Market Size by Region (2016-2021)
2.3.1 Global Interventional X-ray Contrast and Imaging Agents Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Interventional X-ray Contrast and Imaging Agents Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Interventional X-ray Contrast and Imaging Agents Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Interventional X-ray Contrast and Imaging Agents Sales Forecast by Region (2022-2027)
2.4.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Region (2022-2027)
3 Global Interventional X-ray Contrast and Imaging Agents Competitor Landscape by Players
3.1 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Sales
3.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturer (2016-2021)
3.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue
3.2.1 Key Interventional X-ray Contrast and Imaging Agents Manufacturers Covered: Ranking by Revenue
3.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2016-2021)
3.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Interventional X-ray Contrast and Imaging Agents Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Interventional X-ray Contrast and Imaging Agents Revenue in 2020
3.2.6 Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Interventional X-ray Contrast and Imaging Agents Price by Manufacturers
3.4 Global Interventional X-ray Contrast and Imaging Agents Manufacturing Base Distribution, Product Types
3.4.1 Interventional X-ray Contrast and Imaging Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Interventional X-ray Contrast and Imaging Agents Product Type
3.4.3 Date of International Manufacturers Enter into Interventional X-ray Contrast and Imaging Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Interventional X-ray Contrast and Imaging Agents Market Size by Type (2016-2021)
4.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2021)
4.1.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2016-2021)
4.1.3 Interventional X-ray Contrast and Imaging Agents Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Interventional X-ray Contrast and Imaging Agents Market Size Forecast by Type (2022-2027)
4.2.1 Global Interventional X-ray Contrast and Imaging Agents Sales Forecast by Type (2022-2027)
4.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Type (2022-2027)
4.2.3 Interventional X-ray Contrast and Imaging Agents Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Interventional X-ray Contrast and Imaging Agents Market Size by Application (2016-2021)
5.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2021)
5.1.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2016-2021)
5.1.3 Interventional X-ray Contrast and Imaging Agents Price by Application (2016-2021)
5.2 Interventional X-ray Contrast and Imaging Agents Market Size Forecast by Application (2022-2027)
5.2.1 Global Interventional X-ray Contrast and Imaging Agents Sales Forecast by Application (2022-2027)
5.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Application (2022-2027)
5.2.3 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Interventional X-ray Contrast and Imaging Agents Market Size YoY Growth 2016-2027
6.1.1 United States Interventional X-ray Contrast and Imaging Agents Sales YoY Growth 2016-2027
6.1.2 United States Interventional X-ray Contrast and Imaging Agents Revenue YoY Growth 2016-2027
6.1.3 United States Interventional X-ray Contrast and Imaging Agents Market Share in Global Market 2016-2027
6.2 United States Interventional X-ray Contrast and Imaging Agents Market Size by Players (International and Local Players)
6.2.1 United States Top Interventional X-ray Contrast and Imaging Agents Players by Sales (2016-2021)
6.2.2 United States Top Interventional X-ray Contrast and Imaging Agents Players by Revenue (2016-2021)
6.3 United States Interventional X-ray Contrast and Imaging Agents Historic Market Review by Type (2016-2021)
6.3.1 United States Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2016-2021)
6.3.2 United States Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2016-2021)
6.3.3 United States Interventional X-ray Contrast and Imaging Agents Price by Type (2016-2021)
6.4 United States Interventional X-ray Contrast and Imaging Agents Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Interventional X-ray Contrast and Imaging Agents Sales Forecast by Type (2022-2027)
6.4.2 United States Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Type (2022-2027)
6.4.3 United States Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2022-2027)
6.5 United States Interventional X-ray Contrast and Imaging Agents Historic Market Review by Application (2016-2021)
6.5.1 United States Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2016-2021)
6.5.2 United States Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2016-2021)
6.5.3 United States Interventional X-ray Contrast and Imaging Agents Price by Application (2016-2021)
6.6 United States Interventional X-ray Contrast and Imaging Agents Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Interventional X-ray Contrast and Imaging Agents Sales Forecast by Application (2022-2027)
6.6.2 United States Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Application (2022-2027)
6.6.3 United States Interventional X-ray Contrast and Imaging Agents Price Forecast by Application (2022-2027)
7 North America
7.1 North America Interventional X-ray Contrast and Imaging Agents Market Size YoY Growth 2016-2027
7.2 North America Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
7.2.1 North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021)
7.2.2 North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Size YoY Growth 2016-2027
8.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Region
8.2.1 Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Region (2016-2021)
8.2.2 Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Interventional X-ray Contrast and Imaging Agents Market Size YoY Growth 2016-2027
9.2 Europe Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
9.2.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021)
9.2.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Interventional X-ray Contrast and Imaging Agents Market Size YoY Growth 2016-2027
10.2 Latin America Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
10.2.1 Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021)
10.2.2 Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Market Facts & Figures by Country
11.2.1 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021)
11.2.2 Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Bracco
12.1.1 Bracco Corporation Information
12.1.2 Bracco Description and Business Overview
12.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bracco Interventional X-ray Contrast and Imaging Agents Products Offered
12.1.5 Bracco Recent Development
12.2 General Electric
12.2.1 General Electric Corporation Information
12.2.2 General Electric Description and Business Overview
12.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.2.4 General Electric Interventional X-ray Contrast and Imaging Agents Products Offered
12.2.5 General Electric Recent Development
12.3 Guerbet
12.3.1 Guerbet Corporation Information
12.3.2 Guerbet Description and Business Overview
12.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Guerbet Interventional X-ray Contrast and Imaging Agents Products Offered
12.3.5 Guerbet Recent Development
12.4 Fujifilm Visualsonics
12.4.1 Fujifilm Visualsonics Corporation Information
12.4.2 Fujifilm Visualsonics Description and Business Overview
12.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Products Offered
12.4.5 Fujifilm Visualsonics Recent Development
12.5 Imax
12.5.1 Imax Corporation Information
12.5.2 Imax Description and Business Overview
12.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Imax Interventional X-ray Contrast and Imaging Agents Products Offered
12.5.5 Imax Recent Development
12.6 J.B. Chemicals & Pharmaceuticals
12.6.1 J.B. Chemicals & Pharmaceuticals Corporation Information
12.6.2 J.B. Chemicals & Pharmaceuticals Description and Business Overview
12.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.6.4 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Products Offered
12.6.5 J.B. Chemicals & Pharmaceuticals Recent Development
12.7 Jodas Expoim
12.7.1 Jodas Expoim Corporation Information
12.7.2 Jodas Expoim Description and Business Overview
12.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Products Offered
12.7.5 Jodas Expoim Recent Development
12.8 Lantheus Medical Imaging
12.8.1 Lantheus Medical Imaging Corporation Information
12.8.2 Lantheus Medical Imaging Description and Business Overview
12.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Products Offered
12.8.5 Lantheus Medical Imaging Recent Development
12.9 Nano Therapeutics
12.9.1 Nano Therapeutics Corporation Information
12.9.2 Nano Therapeutics Description and Business Overview
12.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Products Offered
12.9.5 Nano Therapeutics Recent Development
12.10 Novalek Pharmaceuticals
12.10.1 Novalek Pharmaceuticals Corporation Information
12.10.2 Novalek Pharmaceuticals Description and Business Overview
12.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Products Offered
12.10.5 Novalek Pharmaceuticals Recent Development
12.11 Bracco
12.11.1 Bracco Corporation Information
12.11.2 Bracco Description and Business Overview
12.11.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bracco Interventional X-ray Contrast and Imaging Agents Products Offered
12.11.5 Bracco Recent Development
12.12 Unijules Life Sciences
12.12.1 Unijules Life Sciences Corporation Information
12.12.2 Unijules Life Sciences Description and Business Overview
12.12.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Unijules Life Sciences Products Offered
12.12.5 Unijules Life Sciences Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Interventional X-ray Contrast and Imaging Agents Industry Trends
13.2 Interventional X-ray Contrast and Imaging Agents Market Drivers
13.3 Interventional X-ray Contrast and Imaging Agents Market Challenges
13.4 Interventional X-ray Contrast and Imaging Agents Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Interventional X-ray Contrast and Imaging Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Iodinated Contrast Media
Table 3. Major Manufacturers of Barium-Based Contrast Media
Table 4. Major Manufacturers of Microbubble Contrast Media
Table 5. Major Manufacturers of Other
Table 6. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 7. Global Interventional X-ray Contrast and Imaging Agents Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Interventional X-ray Contrast and Imaging Agents Sales by Regions (2016-2021) & (K MT)
Table 9. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Regions (2016-2021)
Table 10. Global Interventional X-ray Contrast and Imaging Agents Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Interventional X-ray Contrast and Imaging Agents Sales Forecast by Region (2022-2027) & (K MT)
Table 12. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers (2016-2021) (K MT)
Table 16. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Interventional X-ray Contrast and Imaging Agents Manufacturers by Revenue (US$ Million) in 2020
Table 18. Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Interventional X-ray Contrast and Imaging Agents Revenue Share by Manufacturers (2016-2021)
Table 20. Global Interventional X-ray Contrast and Imaging Agents Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Interventional X-ray Contrast and Imaging Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interventional X-ray Contrast and Imaging Agents as of 2020)
Table 22. Key Manufacturers Interventional X-ray Contrast and Imaging Agents Price (2016-2021) (USD/MT)
Table 23. Interventional X-ray Contrast and Imaging Agents Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Interventional X-ray Contrast and Imaging Agents Product Type
Table 25. Date of International Manufacturers Enter into Interventional X-ray Contrast and Imaging Agents Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2016-2021) (K MT)
Table 28. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Type (2016-2021)
Table 29. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Type (2016-2021)
Table 31. Interventional X-ray Contrast and Imaging Agents Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 32. Global Interventional X-ray Contrast and Imaging Agents Sales Forecast by Type (2022-2027) & (K MT)
Table 33. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Interventional X-ray Contrast and Imaging Agents Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 37. Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2016-2021) (K MT)
Table 38. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Application (2016-2021)
Table 39. Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Application (2016-2021)
Table 41. Interventional X-ray Contrast and Imaging Agents Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 42. Global Interventional X-ray Contrast and Imaging Agents Sales Forecast by Application (2022-2027) & (K MT)
Table 43. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Interventional X-ray Contrast and Imaging Agents Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Interventional X-ray Contrast and Imaging Agents Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 47. United States Interventional X-ray Contrast and Imaging Agents Sales (K MT) of Key Companies (2016-2021)
Table 48. United States Interventional X-ray Contrast and Imaging Agents Sales Share by Company (2016-2021)
Table 49. United States Interventional X-ray Contrast and Imaging Agents Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Interventional X-ray Contrast and Imaging Agents Revenue Share by Company (2016-2021)
Table 51. United States Interventional X-ray Contrast and Imaging Agents Sales (K MT) by Type (2016-2021)
Table 52. United States Interventional X-ray Contrast and Imaging Agents Sales Share by Type (2016-2021)
Table 53. United States Interventional X-ray Contrast and Imaging Agents Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Interventional X-ray Contrast and Imaging Agents Price (USD/MT) by Type (2016-2021)
Table 55. United States Interventional X-ray Contrast and Imaging Agents Sales (K MT) by Type (2022-2027)
Table 56. United States Interventional X-ray Contrast and Imaging Agents Sales Share by Type (2022-2027)
Table 57. United States Interventional X-ray Contrast and Imaging Agents Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Interventional X-ray Contrast and Imaging Agents Revenue Share by Type (2022-2027)
Table 59. United States Interventional X-ray Contrast and Imaging Agents Price (USD/MT) by Type (2022-2027)
Table 60. United States Interventional X-ray Contrast and Imaging Agents Sales (K MT) by Application (2016-2021)
Table 61. United States Interventional X-ray Contrast and Imaging Agents Sales Share by Application (2016-2021)
Table 62. United States Interventional X-ray Contrast and Imaging Agents Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Interventional X-ray Contrast and Imaging Agents Price (USD/MT) by Application (2016-2021)
Table 64. United States Interventional X-ray Contrast and Imaging Agents Sales (K MT) by Application (2022-2027)
Table 65. United States Interventional X-ray Contrast and Imaging Agents Sales Share by Application (2022-2027)
Table 66. United States Interventional X-ray Contrast and Imaging Agents Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Interventional X-ray Contrast and Imaging Agents Revenue Share by Application (2022-2027)
Table 68. United States Interventional X-ray Contrast and Imaging Agents Price (USD/MT) by Application (2022-2027)
Table 69. North America Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021) & (K MT)
Table 70. North America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Country (2016-2021)
Table 71. North America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales by Region (2016-2021) & (K MT)
Table 74. Asia Pacific Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2016-2021)
Table 77. Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021) & (K MT)
Table 78. Europe Interventional X-ray Contrast and Imaging Agents Sales Market Share by Country (2016-2021)
Table 79. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Country (2016-2021)
Table 81. Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021) & (K MT)
Table 82. Latin America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales by Country (2016-2021) & (K MT)
Table 86. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Country (2016-2021)
Table 89. Bracco Corporation Information
Table 90. Bracco Description and Business Overview
Table 91. Bracco Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 92. Bracco Interventional X-ray Contrast and Imaging Agents Product
Table 93. Bracco Recent Development
Table 94. General Electric Corporation Information
Table 95. General Electric Description and Business Overview
Table 96. General Electric Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 97. General Electric Product
Table 98. General Electric Recent Development
Table 99. Guerbet Corporation Information
Table 100. Guerbet Description and Business Overview
Table 101. Guerbet Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 102. Guerbet Product
Table 103. Guerbet Recent Development
Table 104. Fujifilm Visualsonics Corporation Information
Table 105. Fujifilm Visualsonics Description and Business Overview
Table 106. Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 107. Fujifilm Visualsonics Product
Table 108. Fujifilm Visualsonics Recent Development
Table 109. Imax Corporation Information
Table 110. Imax Description and Business Overview
Table 111. Imax Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 112. Imax Product
Table 113. Imax Recent Development
Table 114. J.B. Chemicals & Pharmaceuticals Corporation Information
Table 115. J.B. Chemicals & Pharmaceuticals Description and Business Overview
Table 116. J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 117. J.B. Chemicals & Pharmaceuticals Product
Table 118. J.B. Chemicals & Pharmaceuticals Recent Development
Table 119. Jodas Expoim Corporation Information
Table 120. Jodas Expoim Description and Business Overview
Table 121. Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 122. Jodas Expoim Product
Table 123. Jodas Expoim Recent Development
Table 124. Lantheus Medical Imaging Corporation Information
Table 125. Lantheus Medical Imaging Description and Business Overview
Table 126. Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 127. Lantheus Medical Imaging Product
Table 128. Lantheus Medical Imaging Recent Development
Table 129. Nano Therapeutics Corporation Information
Table 130. Nano Therapeutics Description and Business Overview
Table 131. Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 132. Nano Therapeutics Product
Table 133. Nano Therapeutics Recent Development
Table 134. Novalek Pharmaceuticals Corporation Information
Table 135. Novalek Pharmaceuticals Description and Business Overview
Table 136. Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 137. Novalek Pharmaceuticals Product
Table 138. Novalek Pharmaceuticals Recent Development
Table 139. Taejoon Pharm Corporation Information
Table 140. Taejoon Pharm Description and Business Overview
Table 141. Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 142. Taejoon Pharm Product
Table 143. Taejoon Pharm Recent Development
Table 144. Unijules Life Sciences Corporation Information
Table 145. Unijules Life Sciences Description and Business Overview
Table 146. Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Unijules Life Sciences Product
Table 148. Unijules Life Sciences Recent Development
Table 149. Interventional X-ray Contrast and Imaging Agents Market Trends
Table 150. Interventional X-ray Contrast and Imaging Agents Market Drivers
Table 151. Interventional X-ray Contrast and Imaging Agents Market Challenges
Table 152. Interventional X-ray Contrast and Imaging Agents Market Restraints
Table 153. Interventional X-ray Contrast and Imaging Agents Customers List
Table 154. Interventional X-ray Contrast and Imaging Agents Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Interventional X-ray Contrast and Imaging Agents Product Picture
Figure 2. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type in 2020 & 2027
Figure 3. Iodinated Contrast Media Produc
  • Global Gynecology Partnering 2010-2021: Deal trends, players and financials
    Published: 01-Dec-2021        Price: US 3495 Onwards        Pages: 300
    Global Gynecology Partnering 2010-2021: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Gynecology partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gynecology partnering agreement structure Gynecology partnering contract documents Top Gynecology deals by value Most active......
  • Global Fiberoptic Laryngoscope Market Research Report 2021
    Published: 29-Nov-2021        Price: US 2900 Onwards        Pages: 116
    The global Fiberoptic Laryngoscope market was valued at US$ 64.43 million in 2020 and is expected to reach US$ 105.99 million by the end of 2027, growing at a CAGR of 6.77% during 2021-2027. This report focuses on Fiberoptic Laryngoscope volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Fiberoptic Laryngoscope market size by analysing historical data and future prospect. Regionally, this report focuses on sev......
  • Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2021-2027
    Published: 29-Nov-2021        Price: US 3900 Onwards        Pages: 173
    Market Analysis and Insights: Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market This report focuses on global and Japan Beta-lactam and Beta-lactamase Inhibitors market. In 2020, the global Beta-lactam and Beta-lactamase Inhibitors market size was US$ 23715 million and it is expected to reach US$ 31774 million by the end of 2027, with a CAGR of 1.93% during 2021-2027. In Japan the Beta-lactam and Beta-lactamase Inhibitors market size is expected to grow from US$ 202......
  • Global Defibrillators Pads Market Research Report 2021
    Published: 29-Nov-2021        Price: US 2900 Onwards        Pages: 110
    The global Defibrillators Pads market was valued at US$ 167.30 million in 2020 and is expected to reach US$ 277.83 million by the end of 2027, growing at a CAGR of 6.86% during 2021-2027. This report focuses on Defibrillators Pads volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Defibrillators Pads market size by analysing historical data and future prospect. Regionally, this report focuses on several key re......
  • Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026
    Published: 29-Nov-2021        Price: US 4950 Onwards        Pages: 181
    “Increasing blood transfusion and donations is expected to drive the overall growth of the hepatitis testing market.” The global hepatitis testing market is projected to reach USD 3.6 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 4.7% during the forecast period. The growth of the global hepatitis testing market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instrumen......
  • Global and Japan PCR Hoods Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 142
    PCR Hoods market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global PCR Hoods market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the PCR Hoods market size by players, by ......
  • Global and United States Medical Shower Beds Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 144
    Medical Shower Beds market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Shower Beds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Medical S......
  • Global and Japan Orthopaedic Robotic System Market Insights, Forecast to 2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 135
    Orthopaedic Robotic System market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Orthopaedic Robotic System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Ort......
  • Global and China Cardiotoxicity Screening Market Size, Status and Forecast 2021-2027
    Published: 18-Nov-2021        Price: US 3900 Onwards        Pages: 108
    Global Cardiotoxicity Screening Scope and Market Size Cardiotoxicity Screening market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cardiotoxicity Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segm......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs